Related Experiment Video
Updated: May 18, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Methylthioadenosine phosphorylase inactivation depends on gene deletion in laryngeal squamous cell carcinoma
Laura Conde1, Isabel Vilaseca, Llucia Alós
1Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain.
Aims:
Methylthioadenosine phosphorylase (MTAP) is an essential enzyme for the methionine and adenosine salvage pathway in normal cells, frequently inactivated in many different human cancers. MTAP status could be important for tumour cell sensitivity to adjuvant chemotherapy. To our knowledge, there have been no reports to date on MTAP status in laryngeal carcinoma.
Methods And Results:
A series of 31 laryngeal squamous cell carcinomas was investigated for MTAP mRNA expression using reverse transcription and quantitative polymerase chain reaction (qPCR), as well as for MTAP gene deletion and/or promoter hypermethylation using qPCR and methylation-specific PCR, respectively. Low MTAP mRNA expression was found in 32% of cases, and was associated with MTAP gene deletion (in 70%; P<0.001) but not with MTAP promoter hypermethylation, indicating that, in this tumour, gene deletion is the main mechanism for MTAP inactivation. Neither low mRNA expression nor gene deletion was associated with any of the clinicopathological parameters investigated.
Conclusion:
Given the significance of MTAP status for cell sensitivity to different chemotherapeutic regimens, our results suggest that determination of MTAP inactivation should be taken into consideration in managing laryngeal squamous cell carcinomas.
Insights
Methylthioadenosine phosphorylase (MTAP) is frequently lost in cancers. In laryngeal cancer, gene deletion, not methylation, mainly causes MTAP inactivation, impacting treatment decisions.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Methylthioadenosine phosphorylase (MTAP) is crucial for cellular salvage pathways.
- MTAP inactivation is common in various human cancers.
- MTAP status may influence tumor response to chemotherapy.
Purpose of the Study:
- To investigate MTAP status in laryngeal carcinoma for the first time.
- To determine the mechanisms of MTAP inactivation in this cancer type.
Main Methods:
- Analysis of 31 laryngeal squamous cell carcinomas.
- Quantification of MTAP mRNA expression via RT-qPCR.
- Assessment of MTAP gene deletion and promoter hypermethylation using qPCR and methylation-specific PCR.
Main Results:
- Low MTAP mRNA expression was observed in 32% of cases.
- MTAP gene deletion was the primary mechanism of inactivation (70% of low expression cases), not promoter hypermethylation.
- No association was found between MTAP status and clinicopathological parameters.
Conclusions:
- MTAP gene deletion is the main cause of MTAP inactivation in laryngeal squamous cell carcinoma.
- Assessing MTAP status is recommended for managing laryngeal cancer patients.
- Understanding MTAP inactivation is vital for tailoring chemotherapy regimens.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Biosynthesis of Nucleic Acids
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

